 
															Investor Relations
Why Invest in Sun
Sunshine Holdings PLC offers a unique investment opportunity across Healthcare, Consumer, and Agribusiness. A fully integrated healthcare segment, complemented by strong market positions within the consumer segment, makes SUN a defensive portfolio with sustainable growth prospects. Backed by a solid financial position, disciplined capital management, and a commitment to sustainable and ethical practices, SUN continues to deliver long-term value to all its stakeholders.
Key Highlights
Total revenue bysectors
Agri
Consumer
No Data Found
Healthcare
No Data Found
Agri
Consumer
Healthcare
market cap
Sunshine Holdings PLC Market Cap (LKRbn)
No Data Found
key statistics
LKR
Q1FY25
+12.4%
YoY
Q1FY25
+40%
YoY
LKR
Q1FY25
+5.1%
YoY
LKR
Q1FY25
+19.0%
YoY
LKR
Q1FY25
+10.5%
YoY
TTM
+120
bps
Q1FY25
+12.4%
bps
Q1FY25
+40
bps
Q1FY25
+5.1%
bps
Q1FY25
+19.0%
bps
Q1FY25
+10.5%
bps
TTM
+120
bps
leverage
No Data Found
share price
stock market
Real-Time Share Insights
Stay informed with real-time updates of Sunshine Holdings’ share price and market performance on the Colombo Stock Exchange. View live stock charts, daily movements, and trading insights — helping you track value creation and make informed decisions.
Financial reports
Unlocking Value ThroughInvestor Insights
Quarterly Reports 2025/26
Investor Webinar and Presentation
4QFY23
3QFY23
2QFY23
1QFY23
4QFY22
3QFY22
2QFY22
1QFY22
4QFY21
3QFY21
2QFY21
1QFY21
4QFY20
3QFY20
2QFY20
1QFY20
4QFY19
3QFY19
2QFY19
1QFY19
Financial Calender
Count Down to Key Events
Result Release
Q2 Results Release
FY25
06
2025
Q2
Q3 Results Release
FY25
02
2025
Q3
Q4 Results Release
FY25
29
2026
Q4
Q4 Results Release
FY26
31
2026
Q1
Events and notices
Investor Webinar
Q2 Performance & Outlook
25
2025
Investor Webinar
Q2 Performance & Outlook
25
2025
sign up
Stay Connected With SUN
Signup for Investor Webinar and investor relations mails.
contact us
Connect with Our Team
For all matters related to Sunshine Holdings PLC’s financial performance, corporate disclosures, governance practices, or other investor and analyst inquiries, our Investor Relations team can be reached through the following contact details:
Investor Relations
No.60, Dharmapala Mawatha, Colombo 03, Sri Lanka.
+94 11 4 702 400
 
		 
		 
															 
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
															 
															 
															 
																		